Skip to main content
logo
Faeth Therapeutics, Inc. (FTH)
NASDAQ: FTH · Real-Time Price · USD
24.75
-0.18 (-0.70%)
Oct 8, 2026, 10:38 AM EDT - Market open

Faeth Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-195.53-21.09-30.16-34.1-48.59-36.79
Depreciation & Amortization
0.120.141.321.351.350.69
Loss (Gain) From Sale of Assets
-0.02--0.3-0.02-0.03
Asset Writedown & Restructuring Costs
132.96-0.95---
Loss (Gain) From Sale of Investments
-1.38-0.7-0.99-1.060.220.62
Stock-Based Compensation
17.931.273.144.455.815.66
Other Operating Activities
1.511.511.551.361.19-0.51
Change in Accounts Payable
0.590.23-0.45-2.332.02-1.43
Change in Other Net Operating Assets
9.96-1.83-0.04-2-1.011.54
Operating Cash Flow
-33.86-20.45-24.67-32.02-39.03-30.26
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.01-0.02-0.15-0.18-0.32-2.03
Sale of Property, Plant & Equipment
-0.25-0.170.020.32
Cash Acquisitions
6.46-----
Investment in Securities
-142.1419.5422.5938.4350.26-141.41
Investing Cash Flow
-135.6819.7722.4438.4149.95-143.12

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
--0.79-0.81-0.76-0.63-0.26
Net Debt Issued (Repaid)
-0.35-0.79-0.81-0.76-0.63-0.26
Issuance of Common Stock
1.130.010.030.050.34140.7
Repurchase of Common Stock
-0-0-0.01-10.46--
Other Financing Activities
-16.910.14----
Financing Cash Flow
183.88-0.65-0.79-11.17-0.29163.94

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
14.35-1.33-3.02-4.7810.64-9.44

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-33.86-20.47-24.82-32.2-39.35-32.29
Free Cash Flow Growth
------
Free Cash Flow Per Share
-14.28-16.23-19.76-23.04-25.63-23.30
Levered Free Cash Flow
0.86-12.61-14.71-21.38-22.49-17.56
Unlevered Free Cash Flow
0.88-12.59-14.65-21.29-22.36-17.14

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
10.56-1.59-0.49-4.331.010.12
SEC Filings: 10-K · 10-Q